{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:48:08Z","timestamp":1783493288637,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.mayocp.2012.11.004","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T05:34:28Z","timestamp":1356586468000},"page":"1-3","source":"Crossref","is-referenced-by-count":3,"title":["PSA: Please Stop Agonizing (Over Prostate-Specific Antigen Interpretation)"],"prefix":"10.1016","volume":"88","author":[{"given":"Derek","family":"Raghavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mayocp.2012.11.004_bib1","first-page":"3874","article-title":"Use of human prostate-specific antigen in monitoring prostate cancer","volume":"41","author":"Kuriyama","year":"1981","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.mayocp.2012.11.004_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/djj129","article-title":"Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16","volume":"98","author":"Petrylak","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"24","key":"10.1016\/j.mayocp.2012.11.004_bib3","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1200\/JCO.2006.06.4246","article-title":"Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162)","volume":"24","author":"Hussain","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.11.004_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1470-2045(08)70340-1","article-title":"Circulating tumor cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data","volume":"10","author":"Scher","year":"2009","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.11.004_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-157-2-201207170-00463","article-title":"What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation","volume":"157","author":"Catalona","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2012.11.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2011.07.067","article-title":"Baseline prostate-specific antigen testing at a young age","volume":"61","author":"Loeb","year":"2012","journal-title":"Eur Urol"},{"issue":"13","key":"10.1016\/j.mayocp.2012.11.004_bib7","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomised European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2012.11.004_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1113135","article-title":"Prostate-cancer mortality at 11 years of follow-up","volume":"366","author":"Schr\u00f6der","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.mayocp.2012.11.004_bib9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1470-2045(10)70146-7","article-title":"Mortality results from the G\u00f6teborg randomised population-based prostate-cancer screening trial","volume":"11","author":"Hugosson","year":"2010","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.mayocp.2012.11.004_bib10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2012.11.004_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-155-11-201112060-00375","article-title":"Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force","volume":"155","author":"Chou","year":"2011","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2012.11.004_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.urolonc.2011.12.010","article-title":"The Society of Urologic Oncology\u2019s reply to the US Preventative Services Task Force\u2019s recommendation on PSA testing","volume":"30","author":"Messing","year":"2012","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2012.11.004_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3322\/canjclin.39.1.3","article-title":"Cancer statistics, 1989","volume":"39","author":"Silverberg","year":"1989","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.mayocp.2012.11.004_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.mayocp.2012.11.004_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mayocp.2012.10.012","article-title":"Effect of physical activity on serum PSA levels: results from the National Health and Nutrition Examination Survey (NHANES) (2003-2006)","volume":"88","author":"Loprinzi","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mayocp.2012.11.004_bib16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ejca.2004.12.033","article-title":"Changing demography of prostate cancer in Asia","volume":"41","author":"Sim","year":"2005","journal-title":"Eur J Cancer"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612010919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612010919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T17:28:42Z","timestamp":1539970122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619612010919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0025619612010919"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.11.004","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}